Medical Care
Global Age Related Macular Degeneration (AMD) Market Research Report 2024
- Jan 26, 24
- ID: 27097
- Pages: 75
- Figures: 142
- Views: 28
The global Age Related Macular Degeneration (AMD) market was valued at US$ 7725.7 million in 2023 and is anticipated to reach US$ 11400 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration (AMD).
Report Scope
The Age Related Macular Degeneration (AMD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age Related Macular Degeneration (AMD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age Related Macular Degeneration (AMD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Segment by Type
Wet AMD
Dry AMD
Segment by Application
Men
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration (AMD).
Report Scope
The Age Related Macular Degeneration (AMD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age Related Macular Degeneration (AMD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age Related Macular Degeneration (AMD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Segment by Type
Wet AMD
Dry AMD
Segment by Application
Men
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2019-2030)
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Global Age Related Macular Degeneration (AMD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2019-2024)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2019-2024)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2024)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2023
3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2019-2024)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2019-2024)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
6.2 North America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2019-2030)
7.2 Europe Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2019-2030)
8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
9.2 Latin America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
9.4 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2019-2030)
10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Detail
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.2.5 F. HoffmannLa Roche Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Detail
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.3.5 Regeneron Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Valeant
11.5.1 Valeant Company Detail
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.5.5 Valeant Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2019-2030)
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Global Age Related Macular Degeneration (AMD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2019-2024)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2019-2024)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2024)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2023
3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2019-2024)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2019-2024)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
6.2 North America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2019-2030)
7.2 Europe Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2019-2030)
8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
9.2 Latin America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
9.4 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2019-2030)
10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Detail
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.2.5 F. HoffmannLa Roche Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Detail
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.3.5 Regeneron Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Valeant
11.5.1 Valeant Company Detail
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.5.5 Valeant Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age Related Macular Degeneration (AMD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Age Related Macular Degeneration (AMD) Market Share by Region (2019-2024)
Table 8. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Age Related Macular Degeneration (AMD) Market Share by Region (2025-2030)
Table 10. Age Related Macular Degeneration (AMD) Market Trends
Table 11. Age Related Macular Degeneration (AMD) Market Drivers
Table 12. Age Related Macular Degeneration (AMD) Market Challenges
Table 13. Age Related Macular Degeneration (AMD) Market Restraints
Table 14. Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Age Related Macular Degeneration (AMD) Market Share by Players (2019-2024)
Table 16. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2023)
Table 17. Ranking of Global Top Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Date of Enter into Age Related Macular Degeneration (AMD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2019-2024)
Table 25. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2025-2030)
Table 27. Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2019-2024)
Table 29. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2025-2030)
Table 31. North America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Age Related Macular Degeneration (AMD) Product
Table 49. Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. F. HoffmannLa Roche Company Detail
Table 52. F. HoffmannLa Roche Business Overview
Table 53. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product
Table 54. F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 55. F. HoffmannLa Roche Recent Development
Table 56. Regeneron Company Detail
Table 57. Regeneron Business Overview
Table 58. Regeneron Age Related Macular Degeneration (AMD) Product
Table 59. Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 60. Regeneron Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Age Related Macular Degeneration (AMD) Product
Table 64. Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Valeant Company Detail
Table 67. Valeant Business Overview
Table 68. Valeant Age Related Macular Degeneration (AMD) Product
Table 69. Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 70. Valeant Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Age Related Macular Degeneration (AMD) Product
Table 74. Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2023 VS 2030
Figure 3. Wet AMD Features
Figure 4. Dry AMD Features
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Age Related Macular Degeneration (AMD) Market Share by Application: 2023 VS 2030
Figure 7. Men Case Studies
Figure 8. Woman Case Studies
Figure 9. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 10. Global Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Age Related Macular Degeneration (AMD) Market Share by Region: 2023 VS 2030
Figure 13. Global Age Related Macular Degeneration (AMD) Market Share by Players in 2023
Figure 14. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2023
Figure 16. North America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 18. United States Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 22. Germany Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Region (2019-2030)
Figure 30. China Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 38. Mexico Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 42. Turkey Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 45. F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 46. Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 48. Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age Related Macular Degeneration (AMD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Age Related Macular Degeneration (AMD) Market Share by Region (2019-2024)
Table 8. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Age Related Macular Degeneration (AMD) Market Share by Region (2025-2030)
Table 10. Age Related Macular Degeneration (AMD) Market Trends
Table 11. Age Related Macular Degeneration (AMD) Market Drivers
Table 12. Age Related Macular Degeneration (AMD) Market Challenges
Table 13. Age Related Macular Degeneration (AMD) Market Restraints
Table 14. Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Age Related Macular Degeneration (AMD) Market Share by Players (2019-2024)
Table 16. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2023)
Table 17. Ranking of Global Top Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Date of Enter into Age Related Macular Degeneration (AMD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2019-2024)
Table 25. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2025-2030)
Table 27. Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2019-2024)
Table 29. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2025-2030)
Table 31. North America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Age Related Macular Degeneration (AMD) Product
Table 49. Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. F. HoffmannLa Roche Company Detail
Table 52. F. HoffmannLa Roche Business Overview
Table 53. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product
Table 54. F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 55. F. HoffmannLa Roche Recent Development
Table 56. Regeneron Company Detail
Table 57. Regeneron Business Overview
Table 58. Regeneron Age Related Macular Degeneration (AMD) Product
Table 59. Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 60. Regeneron Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Age Related Macular Degeneration (AMD) Product
Table 64. Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Valeant Company Detail
Table 67. Valeant Business Overview
Table 68. Valeant Age Related Macular Degeneration (AMD) Product
Table 69. Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 70. Valeant Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Age Related Macular Degeneration (AMD) Product
Table 74. Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2023 VS 2030
Figure 3. Wet AMD Features
Figure 4. Dry AMD Features
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Age Related Macular Degeneration (AMD) Market Share by Application: 2023 VS 2030
Figure 7. Men Case Studies
Figure 8. Woman Case Studies
Figure 9. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 10. Global Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Age Related Macular Degeneration (AMD) Market Share by Region: 2023 VS 2030
Figure 13. Global Age Related Macular Degeneration (AMD) Market Share by Players in 2023
Figure 14. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2023
Figure 16. North America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 18. United States Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 22. Germany Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Region (2019-2030)
Figure 30. China Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 38. Mexico Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
Figure 42. Turkey Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 45. F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 46. Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 48. Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232